Podiatrists in Middletown, RI Accepting Medicare

3 Podiatrists found. Showing 1 - 3

Coastal Foot & Ankle Inc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 850 Aquidneck Ave, Middletown, RI 02842 Phone: 401-849-2157    Fax: 401-848-8441

Jonathan G Sabourin, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 850 Aquidneck Ave Ste 15, Middletown, RI 02842 Phone: 401-849-2157    Fax: 401-848-8441

Douglas Alan Reid, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 850 Aquidneck Ave, Box 15, Middletown, RI 02842 Phone: 401-849-2157    Fax: 401-848-8441

News Archive

A close look at Accutane drug registry iPledge

The Chicago Sun-Times on Monday examined the online FDA tracking database iPledge, with which all people taking Roche's acne drug Accutane much register to receive their prescriptions (Ritter, Chicago Sun-Times, 8/21).

Adipocytes associated with breast cancer could amplify 'aggressive' effect of tumors in obese patients

Apart from its direct effect on health (such as cardiovascular diseases and diabetes), obesity is increasingly suspected of playing a role in the prognosis of breast cancer and, in particular, its propensity to spread. However, no direct cause and effect relationship had been demonstrated until now. This breakthrough has finally been made through the collaborative work of two teams of researchers from Inserm, CNRS and the Université Paul Sabatier.

California prisons are COVID hotbeds despite billions spent on inmate health

From Corcoran and Avenal state prisons in the arid Central Valley to historical San Quentin on the San Francisco Bay, California prisons have emerged as raging COVID-19 hot spots, even as the state annually spends more on inmate health care than other big states spend on their entire prison systems.

FDA grants Breakthrough designation to Dthera Sciences' development-stage product for Alzheimer's

Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.

OmSanA: A new option to maintain healthy blood sugar and cholesterol levels

The holidays should be a time when Americans focus on celebrating, reuniting with loved ones, enjoying holiday feasts and seemingly endless holiday treats. But, for the roughly 127 million Americans that struggle with maintaining healthy blood sugar and cholesterol levels, the stress of nearly two months of festivities can place enormous pressure on a body's ability to maintain normal blood sugar and cholesterol levels.

Read more Medical News

› Verified 3 days ago